In a rare – and possibly unique – turn of events, both pharmacy company Biogen and its shareholders have asked a federal ...

Medicare Advantage may offer coverage, but this varies from plan to plan. You are not required to receive an annual wellness exam, and declining to schedule this visit will not affect your ...

Private insurance companies offer Medicare Advantage plans, so dental coverage may differ for each company. Some plans may only cover preventive services, such as oral exams, while others may ...

Before 2025, if you were enrolled in a Medicare Part D prescription drug plan, it’s possible that you could encounter a coverage gap if you and your plan spent a certain amount on medications in ...

Medicare is a fee-for-service health ... as part of the conditions of issuing you a plan Refuse to sell you a policy Make you wait for coverage to start Charge you more If you are under 65 ...

Medicare doesn’t cover all of your health ... offer plans nationwide by the number of states in which they provide coverage, the number of types of plans they offer, how they rank in terms ...

R. Kelly’s daughter Joanne Kelly, who appears in the upcoming documentary “R Kelly’s Karma: A Daughter’s Journey,” revealed she has no interest in introducing her future son to his ...

David Edwards has spent over a decade reporting on social justice, human rights and politics for Raw Story. He also writes Crooks and Liars. He has a background in enterprise resource planning and ...

Republican vice presidential candidate JD Vance on Wednesday again refused to say who he believed won the 2020 presidential election, which has been the persistent focus of false claims by his ...

AUBURN HILLS, Mich. (AP) — Republican vice presidential candidate JD Vance on Wednesday again refused to say who he believed won the 2020 presidential election, which has been the persistent ...

Boxing promoter Eddie Hearn's defamation lawsuit against Jake Paul is proceeding after a U.S. District Court judge in New York denied a motion to dismiss the case Monday, according to court ...

The big question is whether lecanemab will face the same pushback from clinicians and healthcare payers that afflicted Aduhelm, culminating in the restriction of Medicare reimbursement to patients ...